Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 4/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL914908 | 0.83 | PTPN1 (0.42) | HMGCRGABRA1GABRB2CYP2C19TACR1 | |
| Fluoride SCHEMBL914959 | 0.81 | HMGCR (0.34) | HMGCRGABRA1GABRB2CYP2C19TACR1 | |
| SCHEMBL914312 | 0.81 | HMGCR (0.34) | HMGCRGABRA1GABRB2CYP2C19TACR1 | |
| SCHEMBL914960 | 0.79 | ATM (0.33) | HMGCRGABRA1GABRB2CYP2C19PTPN1 | |
| SCHEMBL12705774 | 0.79 | HMGCR (0.33) | HMGCRGABRA1GABRB2CYP2C19PTPN1 | |
| SCHEMBL12705778 | 0.78 | TACR1 (0.38) | HMGCRGABRA1GABRB2CYP2C19TACR1 | |
| SCHEMBL12353847 | 0.78 | GABRA1 (0.39) | GABRA1GABRB2CYP2C19HTR1DPOLB | |
| SCHEMBL12905796 | 0.76 | HMGCR (0.34) | HMGCRCYP2C19ATM | |
| SCHEMBL12705787 | 0.76 | GABRA1 (0.38) | GABRA1GABRB2CYP2C19HTR1DPOLB | |
| SCHEMBL22022403 | 0.76 | HMGCR (0.49) | HMGCRGABRA1GABRB2TACR1HTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7919635-B2 | Substituted phenylsulfur trifluoride and other like fluorinating agents | UBE INDUSTRIES, LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-20090203924-A1 | SUBSTITUTED PHENYLSULFUR TRIFLUORIDE AND OTHER LIKE FLUORINATING AGENTS | IM&T RESEARCH, INC. (US) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203924-A1 | SUBSTITUTED PHENYLSULFUR TRIFLUORIDE AND OTHER LIKE FLUORINATING AGENTS | PFAS, FRS2, FBL | HMGCR 3386/4885GABRA1 1880/4885GABRB2 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.